Section one: Contracting authority
one.1) Name and addresses
Department of Health and Social Care
39 Victoria Street
London
SW1H 0EU
Contact
Jay Bains
Country
United Kingdom
Region code
UKI32 - Westminster
Internet address(es)
Main address
https://www.gov.uk/government/organisations/department-of-health-and-social-care
Buyer's address
https://www.gov.uk/government/organisations/department-of-health-and-social-care
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://health-family.force.com/s/Welcome
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://health-family.force.com/s/Welcome
Tenders or requests to participate must be submitted to the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
https://health-family.force.com/s/Welcome
one.4) Type of the contracting authority
Ministry or any other national or federal authority
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
DHSC: PCP: Evidence Summaries (4 lots) FY 24/25
Reference number
C294820
two.1.2) Main CPV code
- 73200000 - Research and development consultancy services
two.1.3) Type of contract
Services
two.1.4) Short description
The UK National Screening Committee (UK NSC) advises Ministers and the NHS in the 4 UK countries on all aspects of screening. The UK NSC makes recommendations on whether or not to introduce screening programmes for over 100 conditions. The evidence team, part of the UK NSC Secretariat, hosted by the Department of Health and Social Care, is responsible for managing the evidence review process to ensure UK NSC recommendations remain up to date.
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries.Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises.
This contract has been divided into 4 lots. Each lot corresponds to the following lots
Lot 1 Biliary atresia
Lot 2 Group B strep
Lot 3 Breast Risk Stratification
Lot 4 Targeted Screening
Contract Project Reference: C294820
Contract term: 9 months with the option to extend for up to further 2 months.
Estimated contract value (including extensions) for all the lots (4) is: £248,264 (excluding VAT), £297,916.80 (inclusive of VAT). Each lot (evidence maps) estimated value is: £62,066 (excluding VAT), £74,479.20 (inclusive of VAT)
The contracting authority considers that this future opportunity may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.
The opportunity will be available on the DHSC Atamis eTendering System. Select this link to access and register your organisation to the Atamis system https://health-family.force.com/s/Welcome, if you have not already done so.
To find this opportunity in the eTendering system, select “Find Opportunities” and then search by project number or title. Once you have found the Opportunity, press the ‘Register Interest’ button to register your interest. This will make the project to appear on ‘My proposals and quotes’. From there you can review documents, send clarification messages, submit the response, or decline to respond, if you decide not to participate in the opportunity. For full details on the instruction to tender and terms of participations please refer to the Invitation to Tender document.
Deadline for submission: 21st October 2024 at 12 noon
two.1.5) Estimated total value
Value excluding VAT: £248,264
two.1.6) Information about lots
This contract is divided into lots: Yes
Tenders may be submitted for all lots
Maximum number of lots that may be awarded to one tenderer: 2
two.2) Description
two.2.1) Title
Lot 1-Biliary atresia
Lot No
1
two.2.2) Additional CPV code(s)
- 73200000 - Research and development consultancy services
two.2.3) Place of performance
NUTS codes
- UKI32 - Westminster
two.2.4) Description of the procurement
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot Lot 1 Biliary atresia
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £62,066
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
9
This contract is subject to renewal
Yes
Description of renewals
Additional 2 months at the sole discretion of the Authority and no additional cost.
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 2-Group B strep
Lot No
2
two.2.2) Additional CPV code(s)
- 73200000 - Research and development consultancy services
two.2.3) Place of performance
NUTS codes
- UKI32 - Westminster
two.2.4) Description of the procurement
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 2 Group B strep
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £62,066
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
9
This contract is subject to renewal
Yes
Description of renewals
Additional 2 months at the sole discretion of the Authority and no additional cost.
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 3-Decision analytic model for risk stratification in breast cancer screening
Lot No
3
two.2.2) Additional CPV code(s)
- 73200000 - Research and development consultancy services
two.2.3) Place of performance
NUTS codes
- UKI32 - Westminster
two.2.4) Description of the procurement
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 3 Decision Analytic Model for Risk Stratification
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £62,066
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
9
This contract is subject to renewal
Yes
Description of renewals
Additional 2 months at the sole discretion of the Authority and no additional cost.
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 4-Targeted Screening
Lot No
4
two.2.2) Additional CPV code(s)
- 73200000 - Research and development consultancy services
two.2.3) Place of performance
NUTS codes
- UKI32 - Westminster
two.2.4) Description of the procurement
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 4 Targeted Screening
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £62,066
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
9
This contract is subject to renewal
Yes
Description of renewals
Additional 2 months at the sole discretion of the Authority and no additional cost.
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section three. Legal, economic, financial and technical information
three.1) Conditions for participation
three.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2024/S 000-018132
four.2.2) Time limit for receipt of tenders or requests to participate
Date
21 October 2024
Local time
12:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 6 (from the date stated for receipt of tender)
four.2.7) Conditions for opening of tenders
Date
21 October 2024
Local time
12:00pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.3) Additional information
The UK National Screening Committee (UK NSC) advises Ministers and the NHS in the 4 UK countries on all aspects of screening. The UK NSC makes recommendations on whether or not to introduce screening programmes for over 100 conditions. The evidence team, part of the UK NSC Secretariat, hosted by the Department of Health and Social Care, is responsible for managing the evidence review process to ensure UK NSC recommendations remain up to date.
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries.Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises.
This contract has been divided into 4 lots. Each lot corresponds to the following lots
Lot 1 Biliary atresia
Lot 2 Group B strep
Lot 3 Breast Risk Stratification
Lot 4 Targeted Screening
Contract Project Reference: C294820
Contract term: 9 months with the option to extend for up to further 2 months.
Estimated contract value (including extensions) for all the lots (4) is: £248,264 (excluding VAT), £297,916.80 (inclusive of VAT). Each lot (evidence maps) estimated value is: £62,066 (excluding VAT), £74,479.20 (inclusive of VAT)
The contracting authority considers that this future opportunity may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.
The opportunity will be available on the DHSC Atamis eTendering System. Select this link to access and register your organisation to the Atamis system https://health-family.force.com/s/Welcome, if you have not already done so.
To find this opportunity in the eTendering system, select “Find Opportunities” and then search by project number or title. Once you have found the Opportunity, press the ‘Register Interest’ button to register your interest. This will make the project to appear on ‘My proposals and quotes’. From there you can review documents, send clarification messages, submit the response, or decline to respond, if you decide not to participate in the opportunity. For full details on the instruction to tender and terms of participations please refer to the Invitation to Tender document.
Deadline for submission: 21st October 2024 at 12 noon
six.4) Procedures for review
six.4.1) Review body
The High Court
The Strand
London
WC2A 2LL
Country
United Kingdom
Internet address
https://www.judiciary.uk/courts-and-tribunals/high-court/
six.4.2) Body responsible for mediation procedures
The High Court
Strand
London
WC2A 2LL
generaloffice@administrativecourtoffice.justice.gov.uk
Country
United Kingdom
Internet address
https://www.gov.uk/courts-tribunals
six.4.4) Service from which information about the review procedure may be obtained
The High Court
Strand
London
WC2A 2LL
generaloffice@administrativecourtoffice.justice.gov.uk
Country
United Kingdom